Blood Testing Market Size - By Test Type, By Product, By Method, By End-use, Global Forecast 2023

List of Tables

Blood Testing Market size is poised to depict 6.7% CAGR from 2023-2032 driven by the surging demand for complete blood count (CBC) tests during the COVID-19 pandemic.

CBC tests have proven essential in determining the general health of patients and identifying possible infections, leading to their increased adoption for blood diagnostics in healthcare. With the rising count of COVID-19 patients, the growing concerns of substantial changes in peripheral blood cells, such as lymphopenia and neutrophilia significantly soared. According to previously disclosed data, despite the workforce shortage, diagnostic laboratories in Ontario conducted about 50,000 tests each day in December 2021. This increasing demand for CBC tests among COVID-19 patients proved favorable for the industry growth.

The overall blood testing market is segmented based on test type, product, method, end-use, and region.

With respect to test type, the blood testing market size from the infectious disease screening segment is estimated to depict robust growth through 2032. Blood testing is necessary for the early identification and diagnosis of new infectious illnesses, such as SARS, dengue fever, Lyme disease, Nipah virus encephalitis, and others. The high prevalence of such infectious illnesses, in addition to the developments in diagnostic technology, will drive the segment expansion. For instance, in May 2022, Becton, Dickinson, and Company launched its innovative, fully automated infectious disease molecular diagnostics platform in the U.S.

In terms of end-use, the blood testing market value from the pathology segment is estimated to expand at notable CAGR from 2023 to 2032. The growing incidence of various communicable and non-communicable diseases, such as cancer, cardiovascular disease, gastrointestinal disorders, renal disorders, and urological difficulties have resulted in the need for effective diagnosis and treatment of the diseases. With healthcare systems prioritizing preventive care and personalized medicine, pathology laboratories are expected to be at the forefront of diagnostic and screening services.

Regionally, Europe held sizable share of the blood testing market in 2022 and is set to record substantial growth through 2032. The rising geriatric population base and the substantial prevalence of diabetes along with complications related to it will increase the rate of blood testing regionally. According to estimations presented by the European Parliament on World Diabetes Day 2022, over 32 million individuals in the EU suffer from diabetes. Moreover, the stringent healthcare regulations and the focus on preventive care is leading to the higher adoption of diagnostic services. Increasing innovations in blood testing technologies and the higher commitment to R&D activities will also contribute to the market growth.

Product Code: 2683

Chapter 1 Methodology & Scope

1.1 Market definitions
1.2 Base estimates & working
- 1.2.1 Data collection
1.3 Forecast calculations
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Blood testing industry 360 degree synopsis, 2018 - 2032 (USD Million)
2.2 Business trends
2.3 Regional trends
2.4 Test type trends
2.5 Product trends
2.6 Method trends
2.7 End-use trends

Chapter 3 Blood Testing Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing burden of chronic and infectious diseases
  - 3.2.1.2 Technological advancements in blood testing devices
  - 3.2.1.3 Burgeoning number of point-of-care (POC) testing centers
  - 3.2.1.4 Surging demand for CBC tests during the COVID-19 pandemic
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of blood testing devices
  - 3.2.2.2 Errors associated with blood testing process
3.3 Growth potential analysis
- 3.3.1 By test type
- 3.3.2 By product
- 3.3.3 By method
- 3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
3.6 Technological advancements in blood testing industry, 2022
- 3.6.1 By test
- 3.6.2 By blood testing devices
3.7 Pricing analysis, 2022
- 3.7.1 By testing services (USD)
3.8 Porter's analysis
3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix

Chapter 5 Blood Testing Market Size and Forecast, By Test Type (USD Million)

5.1 Key trends, by test type
5.2 Complete blood count test
5.3 Kidney test- renal profile
5.4 Cholesterol test- lipid profile test
5.5 Blood glucose test
5.6 Antibodies test - rheumatoid factor
5.7 Urine test
5.8 Infectious disease screening
5.9 Cancer test
5.10 Heart test
5.11 Others

Chapter 6 Blood Testing Market Size and Forecast, By Product (USD Million)

6.1 Key trends, by product
6.2 Instruments
6.3 Reagents & kits
6.4 Software

Chapter 7 Blood Testing Market Size and Forecast, By Method (USD Million)

7.1 Key trends, by method
7.2 Automated
7.3 Manual

Chapter 8 Blood Testing Market Size and Forecast, By End-use (USD Million)

8.1 Key trends, by end-use
8.2 Hospitals
8.3 Pathology labs
8.4 Blood banks
8.5 Diagnostic centres
8.6 Others

Chapter 9 Blood Testing Market Size and Forecast, By Region (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 The Netherlands
- 9.3.7 Switzerland
- 9.3.8 Poland
- 9.3.9 Denmark
- 9.3.10 Sweden
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 New Zealand
- 9.4.7 Thailand
- 9.4.8 Indonesia
- 9.4.9 Vietnam
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Colombia
- 9.5.5 Chile
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Turkey

Chapter 10 Company Profiles

10.1 Abbott Laboratories
10.2 F Hoffmann-La Roche ltd
10.3 Bio-Rad Laboratories, Inc
10.4 Danaher (Beckman Coulter Inc. and Radiometer)
10.5 BioMerieux SA.
10.6 Biomerica
10.7 Grifols, A.S
10.8 Becton, Dickinson and Company (BD)
10.9 Thermo Fisher Scientific Inc.
10.10 Siemens Healthineers
10.11 Sinocare Inc. (NIPRO Diagnostics)
10.12 Trinity Biotech
10.13 B. Braun Melsungen AG